Previous studies by our group had confirmed that Dihydrotanshinone I, an essential ingredient in SMB, could inhibit the proliferation and migration of ovarian cancer cells in vitro and in vivo by regulating the PI3K/Akt signaling pathway [42]. Here, AKT1 is linked to ovarian carcinoma.